CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moss, R. B.
Right arrow Articles by Carlo, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moss, R. B.
Right arrow Articles by Carlo, D. J.

Clinical and Diagnostic Laboratory Immunology, May 1998, p. 308-312, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

In Vitro p24 Antigen-Stimulated Lymphocyte Proliferation and beta -Chemokine Production in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Subjects after Immunization with an Inactivated gp120-Depleted HIV-1 Immunogen (Remune)

Ronald B. Moss,1,* Mark R. Wallace,2 Paola Lanza,1 Wieslawa Giermakowska,1 Fred C. Jensen,1 Georgia Theofan,1 Carolyn Chamberlin,2 Steven P. Richieri,1 and Dennis J. Carlo1

The Immune Response Corporation, Carlsbad,1 and Division of Infectious Diseases, U.S. Naval Medical Center, San Diego,2 California

Received 29 December 1997/Returned for modification 16 February 1998/Accepted 26 February 1998

We examined the effect of immune stimulation by a human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) compared to a non-HIV vaccine (influenza) on HIV-1-specific immune responses in HIV-1-seropositive subjects. HIV-1 p24 antigen-stimulated lymphocyte proliferation was not augmented after immunization with the influenza vaccine. In contrast, subjects increased their lymphocyte proliferative responses to p24 antigen after one immunization with HIV-1 immunogen (Remune) (gp120-depleted inactivated HIV-1 in incomplete Freund's adjuvant). Furthermore, p24 antigen-stimulated beta -chemokine production (RANTES, MIP-1alpha , MIP-1beta ) was also augmented after immunization with the HIV-1 immunogen but not influenza vaccine. Taken together, these results suggest that in this cohort, HIV-specific immune responses to p24 antigen can be augmented after immunization with an HIV-1 immunogen. The ability to upregulate immune responses to the more conserved core proteins may have important implications in the development of immunotherapeutic interventions for HIV-1 infection.

* Corresponding author. Mailing address: The Immune Response Corp., 5935 Darwin Ct., Carlsbad, CA 92008. Phone: (760) 431-7080. Fax: (760) 431-8636. E-mail: shotdoc{at}imnr.com.

Clinical and Diagnostic Laboratory Immunology, May 1998, p. 308-312, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.